CClinicalTrials.gg
CompletedNCT02711371Updated Feb 2, 2017

Social and Emotional Brain Function in Cannabis Users

An observational study in Cannabis Dependence, sponsored by University of Electronic Science and Technology of China. Completed at 1 site in Germany. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-02-02.

Sponsored by University of Electronic Science and Technology of China · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
43
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The aim of this functional magnetic resonance imaging (fMRI) study is to find out whether and how social and emotional brain function are altered in dependent cannabis users relative to healthy non-using control subjects after a 28 supervised abstinence period. Previous research in cannabis users has predominantly focused on cognitive functions. Moreover, studies have implicated that observed deficits in cannabis users may regenerate after a prolonged abstinence period. Findings might provide important information with respect to relapse vulnerability.

02

Conditions studied

  • Cannabis Dependence

Browse trials for

Keywords

  • addiction
  • cannabis
  • fMRI
03

In context

Marijuana Abuse

517 studies on the registry are indexed under Marijuana Abuse; 114 are open to participants now.

This study's enrollment of 43 is below the median of 100 across 78 observational studies indexed under Marijuana Abuse.

Browse Marijuana Abuse studies →

Lead sponsor

University of Electronic Science and Technology of China is the lead sponsor of 109 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Cannabis dependent individuals

Inclusion criteria

  • Cannabis dependence according to DSM 4 criteria
  • 28 days of supervised abstinence

Exclusion criteria

Exclusion Criteria:

  • other DSM 4 diagnosis
  • neurological disorders
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
43 participants (actual)
Patient registry
No

Groups and cohorts

  • Cannabis Dependence

    Cannabis dependent individuals according to DSM 4 criteria, aged 18-40 years

    Other: fMRI

  • Healthy

    Healthy controls, socio-demographically matched

    Other: fMRI

Interventions

  • OtherfMRI
06

What researchers measure

Primary outcomes

  1. fMRI neural activation patterns of social-emotional brain processes after 28 day abstinence

    Activity patterns in core regions of the emotion processing \& addiction-related brain networks (e.g. striatal regions, insular cortex, prefrontal cortex) will be assessed after 28-days of abstinence. Alterations will be determined by comparison with matched non-drug using controls

    Time frame: one timepoint = fMRI assessment after 28 day abstinence period

Secondary outcomes

  1. Ratings of subjective experience (pleasantness, rewarding value) will be assessed after 28 days of abstinence

    Self-reported ratings of pleasantness \& rewarding value during soft-pleasant touch.

    Time frame: one timepoint = during fMRI assessment after 28 day abstinence period

  2. Relapse interview assessed with Timeline-Followback Method

    Association between fMRI neural correlates and drug use during follow up period as predictor of relapse

    Time frame: one timepoint = 24 months post-fMRI-session

07

Study locations

1 site
  • University of Bonn / Department of Psychiatry
    Bonn, NRW 53111, Germany
08

References and documents

Publications

  • Zimmermann K, Yao S, Heinz M, Zhou F, Dau W, Banger M, Weber B, Hurlemann R, Becker B. Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing in dependent marijuana users after 28 days of abstinence. Psychopharmacology (Berl). 2018 Mar;235(3):849-859. doi: 10.1007/s00213-017-4803-6. Epub 2017 Dec 2. PubMed 29197984 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 2, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02711371
Lead sponsor
University of Electronic Science and Technology of China
Collaborators
German Research Foundation, University Hospital, Bonn
Responsible party
Benjamin Becker (Prof. Dr. rer. nat., University of Electronic Science and Technology of China) — Principal investigator
First posted
Mar 17, 2016
Start date
Jul 2015
Primary completion
Dec 2016
Completion
Dec 2016
Last update
Feb 2, 2017

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion